CoChat
Sign Up
Cited by 27Pharmaceutical Economics and PolicyPharmaceutical Quality and CounterfeitingLogistics and Transportation Systems

The headache of medicines’ supply in Nigeria: an exploratory study on the most critical challenges of pharmaceutical outbound value chains

Open access
Aigbavboa, Solomon, Mbohwa, Charles·2020·Procedia Manufacturing
DOI 10.1016/j.promfg.2020.02.170
Open this paper in CoChat — free accountOpen PDF

Abstract

The outbound segment of any product’s value chain is very critical in its delivery to the final consumer/customer. In this study, the pharmaceutical supply chains management in Nigeria with emphasis on the challenges of the outbound value chains was investigated. A quantitative survey of all the seven categories of both the private and public sectors of the Nigerian pharmaceutical industry was conducted. Data analysis shows six most critical challenges facing the delivery of medicines in Nigeria. Exploratory factor analysis of the data extracted two main factors out of challenges named “people & competency issues” and “infrastructural & regulatory inadequacies”. Valuable contributions from this study to knowledge, research methodology and policies have been made from the results of this study. The findings will be useful for policy and decision makers in both public and private sectors of the pharmaceutical industry in Nigeria and other resource-poor countries.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.promfg.2020.02.170

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Some studies aimed at identifying the challenges associated with the supply chain systems for medicines or vaccines have been conducted in Nigeria.

    “So far, some studies, aimed at identifying the challenges associated with the supply chain systems for medicines or vaccines, have been conducted in Nigeria [2, 3, 7, 9–11].”

    From Medicines and vaccines supply chains challenges in Nigeria: a scoping review (2022) · cites this paper as [3]

  • Other challenges such as stock-outs, poor supply chain practices, and inadequate human resources have been reported.

    “Other challenges such as stock-outs, poor supply chain practices (e.g., poor inventory, poor forecasting, etc.), and inadequate human resources, amongst other factors, have been reported [3, 7–11].”

    From Medicines and vaccines supply chains challenges in Nigeria: a scoping review (2022) · cites this paper as [3]

  • The review identified human resource challenges in Nigeria's medicine supply chain, including lack of support for personnel involved in medicine logistics, inadequate personnel, lack of human resources, corruption, and killing of personnel due to insurgency.

    “Challenges experienced by pharmacists with the various aspects of the supply chainLack of support for personnel involved in medicine logistics, inadequate personnel, lack of human resources as well as corruption, killing of personnel due to insurgency”

    From Medicines and vaccines supply chains challenges in Nigeria: a scoping review (2022) · cites this paper as [3]

  • The review identified stockouts and related issues in Nigeria's medicine and vaccine supply chains, including stock-outs, substandard medicines, inadequate supply of vaccines, and regular stock-outs of essential medicines due to inefficient inventory management systems, equipment and corruption.

    “Stock-outs, substandard medicines, shortage of vaccine stock and vaccine stock-outs, Regular stock-outs of essential medicines due to inefficient inventory management systems, equipment and corruption, Inadequate supply of vaccines”

    From Medicines and vaccines supply chains challenges in Nigeria: a scoping review (2022) · cites this paper as [3]

  • Many reviewed studies used data from multiple centres across the country or population-based surveys, and thus may be nationally representative.

    “Many of the reviewed studies used data from multiple centres across the country (or population-based surveys) [3, 8, 15, 20, 22–24, 28, 31, 33, 34, 37, 38], and thus, maybe nationally representative.”

    From Medicines and vaccines supply chains challenges in Nigeria: a scoping review (2022) · cites this paper as [3]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 7

  1. Sauls, C. Trend in revenue loss due to expired medication at a large urban hospital in Johannesburg, South Africa. (2016). Unpublished MPH Thesis, University of the Witwatersrand; South Africa.
  2. Oluwatuyi, O. Ileri, O.N. Fake Drugs Syndrome and Implications on National Development. Research Journal in Organizational Psychology & Educational Studies. . 3 (2014). 393 -402
  3. Adebisi, A. O. Access to antiretroviral drugs in rural communities in Nigeria. MPH thesis, Graduate school of biomedical sciences, Icahn School of medicine at Mount Sinai. (2013)
  4. Obuaku, C. Essential Medicines in Nigeria: Foregrounding Access to Affordable Essential Medicines. African Sociological Review. (2014). 41 -60.
  5. Onwuka, C. The relationship between access to medicine and transformational leadership in Nigeria. Ph.D. Thesis, Capella University. (2016).
  6. El Mokrini, A. Dafaoui, E. Berrado, A. El Mhamedi, A. An approach to risk Assessment for Outsourcing Logistics: Case of Pharmaceutical Industry IFAC-PapersOnLine 49-12 (2016). IFAC Conference on Manufacturing Modelling, Management and Control June 28-30, 2016. Troyes, France.
  7. Ettah, L (2017). Press Conference on: Nigerian Macroeconomic Review. March 9, 2017. Lagos, Nigeria

Cited by

Sorted by citations

Related

Authors
Aigbavboa, S., & Mbohwa, C.
Affiliations
University of Johannesburg (ZA)
Corresponding author
Aigbavboa, Solomon
ORCID
Mbohwa, Charles
Venue
Procedia Manufacturing
Publisher
Elsevier BV
Published
2020
Volume
43
Pages
336-343
ISSN
2351-9789 (ISSN-L)
DOI
10.1016/j.promfg.2020.02.170
OpenAlex
W3023492053
Cited by
27
References
27
Citations by year
2026: 2 · 2025: 5 · 2024: 7 · 2023: 6 · 2022: 3 · 2021: 4
FWCI
2.76
Type
journal article
Language
en
Open access
Licence
Locations
Procedia Manufacturing (publishedVersion, cc-by-nc-nd)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pharmaceutical Quality and Counterfeiting
  • Social Sciences › Business, Management and Accounting › Management Information Systems › Logistics and Transportation Systems
Keywords
pharmaceutical supply chain management, drug delivery, supply chain challenges, pharmaceutical industry, human resource competence, Nigeria

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review